日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Potent in vitro synergistic antiviral effects of the pan-coronavirus fusion inhibitor EK1 in combination with RBD-specific antibodies or M(pro) inhibitors

泛冠状病毒融合抑制剂EK1与RBD特异性抗体或M(pro)抑制剂联合使用,具有强大的体外协同抗病毒作用

Xiu, Ruixue; Wang, Yuanzhou; Cai, Wenbo; Wang, Qian; Xie, Minxiang; Wang, Yingdan; Li, Cheng; Wang, Qiao; Huang, Jinghe; Ying, Tianlei; Song, Chuanjun; Lu, Lu; Jiang, Shibo; Xu, Wei

Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adults

N6LS(一种广谱中和HIV的单克隆抗体)的安全性和药代动力学:一项在健康成人中进行的1期开放标签剂量递增研究

Wu, Richard L; Houser, Katherine V; Gaudinski, Martin R; Widge, Alicia T; Awan, Seemal F; Carter, Cristina A; Holman, LaSonji A; Saunders, Jamie; Hendel, Cynthia S; Eshun, Aba; Whalen, William R; Wang, Xiaolin; Arthur, Anita; Cunningham, Jennifer E; Beck, Allison; Casazza, Joseph P; Yamshchikov, Galina V; Rothwell, Ro Shauna; Strom, Larisa; Dittakavi, Tejaswi; Happe, Myra; Hickman, Somia P; Conan-Cibotti, Michelle; Carlton, Kevin; Zhang, Lily; Huang, Yunda; Capparelli, Edmund V; Castro, Mike; Lin, Bob C; O'Connell, Sarah; Flach, Britta S; Bailer, Robert T; Narpala, Sandeep R; Serebryannyy, Leonid; McDermott, Adrian B; Arnold, Frank J; Gall, Jason G; Vazquez, Sandra; Berkowitz, Nina M; Gordon, Ingelise J; Chen, Grace L; Kwong, Peter D; Huang, Jinghe; Pierson, Theodore C; Connors, Mark; Mascola, John R; Zhou, Tongqing; Doria-Rose, Nicole A; Koup, Richard A; Dropulic, Lesia K

A potent and broad CD4 binding site neutralizing antibody with strong ADCC activity from a Chinese HIV-1 elite neutralizer.

一种来自中国HIV-1精英中和者的强效广谱CD4结合位点中和抗体,具有很强的ADCC活性

Wang Yingdan, Ji Ping, Liu Qianying, Jia Nannan, Ma Yunping, Yuan Tianyi, Rehati Palizhati, Chen Jiali, Wen Yumei, Wu Fan, Huang Jinghe

Synergistic impact of macrolide resistance and H3N2 infection on M. pneumoniae outbreak in children

大环内酯类耐药性和H3N2感染对儿童肺炎支原体暴发的协同影响

Chen, Jiali; Wang, Yingdan; Cheng, Juan; Ma, Yunping; Zhang, Xin; Bai, Xuezhou; Rehati, Palizhati; Cui, Huashun; Wu, Fan; Pan, Qiuhui; Huang, Jinghe

Evaluation of Poxvirus-Specific Antibody Response in Monkey Poxvirus-Negative and -Positive Cohorts.

对猴痘病毒阴性和阳性队列中痘病毒特异性抗体反应的评估

Jia Nannan, Ai Lin, Ma Yunping, Hua Chen, Shen Qi, Wang Chen, Li Teng, Wang Yingdan, Li Yunyi, Yang Yin, Zhou Chi, Chen Min, Wu Huanyu, Chen Xin, Lu Lu, Zhou Yanqiu, Huang Jinghe, Wu Fan

Grand Challenges on HIV/AIDS in China - The 5th Symposium, Yunnan 2024

中国艾滋病防治重大挑战——第五届研讨会,云南2024

Chen, Zhiwei; Xu, Jianqing; Jin, Xia; Wang, Jianhua; Huang, Jinghe; Zhang, Hui; Chen, Ling; Deng, Kai; Cai, Weiping; Li, Linghua; Wang, Fusheng; Wu, Zhiwei; Shang, Hong; Wu, Hao

A broadly neutralizing antibody inhibits SARS-CoV-2 variants through a novel mechanism of disrupting spike trimer integrity

一种广谱中和抗体通过一种破坏刺突蛋白三聚体完整性的新机制抑制SARS-CoV-2变异株。

Ma, Yunping; Mao, Qiyu; Wang, Yingdan; Zhang, Zhaoyong; Chen, Jiali; Hao, Aihua; Rehati, Palizhati; Wang, Yanqun; Wen, Yumei; Lu, Lu; Chen, Zhenguo; Zhao, Jincun; Wu, Fan; Sun, Lei; Huang, Jinghe

A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates

一种基于SARS-CoV-2原始毒株RBD的泛沙贝病毒疫苗可在非人灵长类动物中诱导产生针对XBB的强效中和抗体

Liu, Zezhong; Zhou, Jie; Wang, Xinling; Xu, Wei; Teng, Zheng; Chen, Hongyou; Chen, Min; Zhang, Guangxu; Wang, Yuanzhou; Huang, Jinghe; Wang, Qian; Jiang, Shibo; Lu, Lu

Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history

在少数有或无中国天花疫苗接种史的个体中,存在针对猴痘病毒表面蛋白的交叉反应抗体。

Xia, Anqi; Wang, Xiaojie; He, Jiaying; Wu, Wei; Jiang, Weiyu; Xue, Song; Zhang, Qianqian; Gao, Yidan; Han, Yuru; Li, Yaming; Peng, Xiaofang; Xie, Minxiang; Mayer, Christian T; Liu, Jie; Hua, Chen; Sha, Yiou; Xu, Wei; Huang, Jinghe; Ying, Tianlei; Jiang, Shibo; Xie, Youhua; Cai, Qiliang; Lu, Lu; Silva, Israel T; Yuan, Zhenghong; Zhang, Yixiao; Wang, Qiao

Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus other treatment regimens in the chinese type 2 diabetes patients

评估固定比例复方胰岛素德谷胰岛素/利拉鲁肽(IDegLira)与其他治疗方案在中国2型糖尿病患者中的长期成本效益

Wei, Ran; Wang, Weihao; Huang, Xiusheng; Qiao, Jingtao; Huang, Jinghe; Xing, Chang; Pan, Qi; Guo, Lixin